Forbes August 21, 2019
Leah Rosenbaum

Color, a Silicon Valley health tech company that specializes in genomics, received a $4.6 million grant to collaborate with the National Institutes of Health’s “All of Us” research program, the company announced Wednesday. As part of the national study to advance precision medicine for a diverse demographic, Color is the sole company to provide genetic counseling services to the study’s participants.

Members of the Color leadership team say that they are very excited to receive the award. The All of Us study is “breaking new ground in the research community,” CEO Othman Laraki tells Forbes.

The All of Us study began in 2016 with the goal of enrolling one million or more Americans in a study to collect...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Patient / Consumer, Precision Medicine, Provider, Technology
23andMe: What If …
23andMe CEO Anne Wojcicki considers taking company private
Age of Opportunity: Artificial Intelligence and the Precision Medicine Future
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
Precision medicine approach combining AI, DNA and drug testing shows gains against relapsed childhood cancers

Share This Article